The minimally invasive urinary incontinence device market size has grown strongly in recent years. It will grow from $1.25 billion in 2025 to $1.37 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to reliance on traditional open surgical procedures, limited device options for urinary incontinence, growing awareness of female pelvic health, increasing hospital and clinic-based procedures, adoption of tension-free vaginal tape (tvt) systems.
The minimally invasive urinary incontinence device market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to development of advanced mid-urethral and single-incision sling systems, rising investment in home healthcare devices, increasing geriatric population and incontinence prevalence, regulatory approvals for innovative bulking agents and artificial urinary sphincters, integration with smart and robotic-assisted surgical systems. Major trends in the forecast period include rising adoption of minimally invasive surgical procedures, growth in urinary incontinence cases due to aging population, increasing preference for home healthcare management, expansion of mid-urethral sling and sling systems, focus on reducing recovery time and surgical complications.
The growing incidence of prostate cancer is expected to drive the growth of the minimally invasive urinary incontinence device market in the coming years. Prostate cancer, characterized by uncontrolled cell growth in the prostate gland, can lead to significant urinary complications and reduced quality of life. The rising prevalence of the disease is largely attributed to an aging male population, as older age is a major risk factor. Minimally invasive urinary incontinence devices help manage prostate cancer-related urinary issues by providing targeted support to control bladder leakage, restore normal urinary function, and improve patient quality of life. For example, in June 2025, the U.S. Centers for Disease Control and Prevention reported an estimated 255,395 new cases of prostate cancer in 2022, with 33,881 deaths in 2023, highlighting the increasing patient population driving demand for effective urinary incontinence solutions.
Companies in the minimally invasive urinary incontinence device market are focusing on innovations such as neuromodulation therapy to provide effective, long-term symptom management with minimal surgical intervention. Neuromodulation therapy devices are implants that stimulate bladder-controlling nerves to regulate urinary function, helping reduce leakage and improve bladder control. For instance, in December 2023, BlueWind Medical Ltd., a U.S.-based neurostimulation company, launched its Revi implantable tibial neuromodulation (iTNM) device. This battery-free, minimally invasive implant is placed near the ankle during a single outpatient procedure under local anesthesia and is activated via a wearable device, enabling patients to conveniently manage urge urinary incontinence (UUI) at home. This launch exemplifies the trend toward patient-friendly, technologically advanced neuromodulation solutions.
In November 2024, Boston Scientific Corporation acquired Axonics Inc. for approximately \$3.7 billion to expand its minimally invasive urinary incontinence portfolio. This acquisition allows Boston Scientific to strengthen its presence in the high-growth sacral neuromodulation segment, integrate Axonics’ innovative technologies, and offer a comprehensive range of treatment options for urinary and bowel dysfunction. Axonics Inc., a U.S.-based medical technology company, specializes in minimally invasive urinary incontinence devices, and this strategic move is expected to drive long-term growth in the urology device market.
Major companies operating in the minimally invasive urinary incontinence device market are Johnson & Johnson Services Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast A/S, Teleflex Incorporated, Hollister Incorporated, CooperSurgical Inc., B. Braun Melsungen Aktiengesellschaft, LiNA Medical ApS, BlueWind Medical Ltd., Caldera Medical Inc., Neuspera Medical Inc., InControl Medical LLC, UroMems Inc., Rigicon Inc., Valencia Technologies Corporation, Zephyr Surgical Implants SA.
North America was the largest region in the minimally invasive urinary incontinence device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive urinary incontinence device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the minimally invasive urinary incontinence device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the minimally invasive urinary incontinence device market by increasing the cost of imported medical devices and surgical instruments, particularly tension-free vaginal tapes and sling systems. Segments such as mid-urethral slings and bulking agents are most affected, with regions like Asia-Pacific and Europe experiencing cost escalations due to import duties. While tariffs have added financial pressure on manufacturers, they also encourage local production, innovation in device design, and expansion of domestic manufacturing capabilities.
The minimally invasive urinary incontinence device market research report is one of a series of new reports that provides minimally invasive urinary incontinence device market statistics, including minimally invasive urinary incontinence device industry global market size, regional shares, competitors with a minimally invasive urinary incontinence device market share, detailed minimally invasive urinary incontinence device market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive urinary incontinence device industry. This minimally invasive urinary incontinence device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A minimally invasive urinary incontinence device is a medical tool designed to treat or manage urinary incontinence using techniques that minimize surgical trauma, shorten recovery time, and reduce complication risks compared to traditional open procedures. These devices function by supporting the urethra, improving sphincter function, or modulating nerve activity to enhance bladder control, and are typically implanted or applied through small incisions, injections, or percutaneous methods.
The primary types of minimally invasive urinary incontinence devices include tension-free vaginal tape (TVT), tension-free vaginal tape obturator system (TVTO), and other variants. Tension-free vaginal tape (TVT) is a minimally invasive procedure that uses a synthetic mesh to support the urethra and prevent stress urinary incontinence in women. These devices are used by adults (18-65 years), seniors (65 years and above), and pediatric patients, and are employed across multiple end-users, including hospitals, clinics, home healthcare settings, and research institutions.
The minimally invasive urinary incontinence device market consists of sales of wearable devices, catheter-based devices, sling systems, adjustable balloon systems and bulking agent delivery systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The minimally invasive urinary incontinence device market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to development of advanced mid-urethral and single-incision sling systems, rising investment in home healthcare devices, increasing geriatric population and incontinence prevalence, regulatory approvals for innovative bulking agents and artificial urinary sphincters, integration with smart and robotic-assisted surgical systems. Major trends in the forecast period include rising adoption of minimally invasive surgical procedures, growth in urinary incontinence cases due to aging population, increasing preference for home healthcare management, expansion of mid-urethral sling and sling systems, focus on reducing recovery time and surgical complications.
The growing incidence of prostate cancer is expected to drive the growth of the minimally invasive urinary incontinence device market in the coming years. Prostate cancer, characterized by uncontrolled cell growth in the prostate gland, can lead to significant urinary complications and reduced quality of life. The rising prevalence of the disease is largely attributed to an aging male population, as older age is a major risk factor. Minimally invasive urinary incontinence devices help manage prostate cancer-related urinary issues by providing targeted support to control bladder leakage, restore normal urinary function, and improve patient quality of life. For example, in June 2025, the U.S. Centers for Disease Control and Prevention reported an estimated 255,395 new cases of prostate cancer in 2022, with 33,881 deaths in 2023, highlighting the increasing patient population driving demand for effective urinary incontinence solutions.
Companies in the minimally invasive urinary incontinence device market are focusing on innovations such as neuromodulation therapy to provide effective, long-term symptom management with minimal surgical intervention. Neuromodulation therapy devices are implants that stimulate bladder-controlling nerves to regulate urinary function, helping reduce leakage and improve bladder control. For instance, in December 2023, BlueWind Medical Ltd., a U.S.-based neurostimulation company, launched its Revi implantable tibial neuromodulation (iTNM) device. This battery-free, minimally invasive implant is placed near the ankle during a single outpatient procedure under local anesthesia and is activated via a wearable device, enabling patients to conveniently manage urge urinary incontinence (UUI) at home. This launch exemplifies the trend toward patient-friendly, technologically advanced neuromodulation solutions.
In November 2024, Boston Scientific Corporation acquired Axonics Inc. for approximately \$3.7 billion to expand its minimally invasive urinary incontinence portfolio. This acquisition allows Boston Scientific to strengthen its presence in the high-growth sacral neuromodulation segment, integrate Axonics’ innovative technologies, and offer a comprehensive range of treatment options for urinary and bowel dysfunction. Axonics Inc., a U.S.-based medical technology company, specializes in minimally invasive urinary incontinence devices, and this strategic move is expected to drive long-term growth in the urology device market.
Major companies operating in the minimally invasive urinary incontinence device market are Johnson & Johnson Services Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast A/S, Teleflex Incorporated, Hollister Incorporated, CooperSurgical Inc., B. Braun Melsungen Aktiengesellschaft, LiNA Medical ApS, BlueWind Medical Ltd., Caldera Medical Inc., Neuspera Medical Inc., InControl Medical LLC, UroMems Inc., Rigicon Inc., Valencia Technologies Corporation, Zephyr Surgical Implants SA.
North America was the largest region in the minimally invasive urinary incontinence device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive urinary incontinence device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the minimally invasive urinary incontinence device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the minimally invasive urinary incontinence device market by increasing the cost of imported medical devices and surgical instruments, particularly tension-free vaginal tapes and sling systems. Segments such as mid-urethral slings and bulking agents are most affected, with regions like Asia-Pacific and Europe experiencing cost escalations due to import duties. While tariffs have added financial pressure on manufacturers, they also encourage local production, innovation in device design, and expansion of domestic manufacturing capabilities.
The minimally invasive urinary incontinence device market research report is one of a series of new reports that provides minimally invasive urinary incontinence device market statistics, including minimally invasive urinary incontinence device industry global market size, regional shares, competitors with a minimally invasive urinary incontinence device market share, detailed minimally invasive urinary incontinence device market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive urinary incontinence device industry. This minimally invasive urinary incontinence device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A minimally invasive urinary incontinence device is a medical tool designed to treat or manage urinary incontinence using techniques that minimize surgical trauma, shorten recovery time, and reduce complication risks compared to traditional open procedures. These devices function by supporting the urethra, improving sphincter function, or modulating nerve activity to enhance bladder control, and are typically implanted or applied through small incisions, injections, or percutaneous methods.
The primary types of minimally invasive urinary incontinence devices include tension-free vaginal tape (TVT), tension-free vaginal tape obturator system (TVTO), and other variants. Tension-free vaginal tape (TVT) is a minimally invasive procedure that uses a synthetic mesh to support the urethra and prevent stress urinary incontinence in women. These devices are used by adults (18-65 years), seniors (65 years and above), and pediatric patients, and are employed across multiple end-users, including hospitals, clinics, home healthcare settings, and research institutions.
The minimally invasive urinary incontinence device market consists of sales of wearable devices, catheter-based devices, sling systems, adjustable balloon systems and bulking agent delivery systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Minimally Invasive Urinary Incontinence Device Market Characteristics
3. Minimally Invasive Urinary Incontinence Device Market Supply Chain Analysis
4. Global Minimally Invasive Urinary Incontinence Device Market Trends and Strategies
5. Minimally Invasive Urinary Incontinence Device Market Analysis of End Use Industries
7. Global Minimally Invasive Urinary Incontinence Device Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Minimally Invasive Urinary Incontinence Device Total Addressable Market (TAM) Analysis for the Market
9. Minimally Invasive Urinary Incontinence Device Market Segmentation
10. Minimally Invasive Urinary Incontinence Device Market Regional and Country Analysis
11. Asia-Pacific Minimally Invasive Urinary Incontinence Device Market
12. China Minimally Invasive Urinary Incontinence Device Market
13. India Minimally Invasive Urinary Incontinence Device Market
14. Japan Minimally Invasive Urinary Incontinence Device Market
15. Australia Minimally Invasive Urinary Incontinence Device Market
16. Indonesia Minimally Invasive Urinary Incontinence Device Market
17. South Korea Minimally Invasive Urinary Incontinence Device Market
18. Taiwan Minimally Invasive Urinary Incontinence Device Market
19. South East Asia Minimally Invasive Urinary Incontinence Device Market
20. Western Europe Minimally Invasive Urinary Incontinence Device Market
21. UK Minimally Invasive Urinary Incontinence Device Market
22. Germany Minimally Invasive Urinary Incontinence Device Market
23. France Minimally Invasive Urinary Incontinence Device Market
24. Italy Minimally Invasive Urinary Incontinence Device Market
25. Spain Minimally Invasive Urinary Incontinence Device Market
26. Eastern Europe Minimally Invasive Urinary Incontinence Device Market
27. Russia Minimally Invasive Urinary Incontinence Device Market
28. North America Minimally Invasive Urinary Incontinence Device Market
29. USA Minimally Invasive Urinary Incontinence Device Market
30. Canada Minimally Invasive Urinary Incontinence Device Market
31. South America Minimally Invasive Urinary Incontinence Device Market
32. Brazil Minimally Invasive Urinary Incontinence Device Market
33. Middle East Minimally Invasive Urinary Incontinence Device Market
34. Africa Minimally Invasive Urinary Incontinence Device Market
36. Minimally Invasive Urinary Incontinence Device Market Competitive Landscape and Company Profiles
37. Minimally Invasive Urinary Incontinence Device Market Other Major and Innovative Companies
40. Minimally Invasive Urinary Incontinence Device Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Minimally Invasive Urinary Incontinence Device Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses minimally invasive urinary incontinence device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for minimally invasive urinary incontinence device? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The minimally invasive urinary incontinence device market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Tension Free Vaginal Tape (TVT); Tension Free Vaginal Tape (TVT) Obturator System; Other Types2) By Age Group: Adults (18-65 years); Senior Population (65 Years And Above); Pediatric Population
3) By End-User: Hospitals; Clinics; Home Healthcare Settings; Research Institutions
Subsegments:
1) By Tension Free Vaginal Tape (TVT): Mid Urethral Sling; Retropubic Sling; Single Incision Sling2) By Tension Free Vaginal Tape Obturator System (TVTO): Inside Out Approach; Outside In Approach
3) By Other Types: Bulking Agents; Artificial Urinary Sphincter; Sling Systems
Companies Mentioned: Johnson & Johnson Services Inc.; Medtronic plc; Becton Dickinson and Company; Stryker Corporation; Boston Scientific Corporation; Olympus Corporation; Coloplast A/S; Teleflex Incorporated; Hollister Incorporated; CooperSurgical Inc.; B. Braun Melsungen Aktiengesellschaft; LiNA Medical ApS; BlueWind Medical Ltd.; Caldera Medical Inc.; Neuspera Medical Inc.; InControl Medical LLC; UroMems Inc.; Rigicon Inc.; Valencia Technologies Corporation; Zephyr Surgical Implants SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Minimally Invasive Urinary Incontinence Device market report include:- Johnson & Johnson Services Inc.
- Medtronic plc
- Becton Dickinson and Company
- Stryker Corporation
- Boston Scientific Corporation
- Olympus Corporation
- Coloplast A/S
- Teleflex Incorporated
- Hollister Incorporated
- CooperSurgical Inc.
- B. Braun Melsungen Aktiengesellschaft
- LiNA Medical ApS
- BlueWind Medical Ltd.
- Caldera Medical Inc.
- Neuspera Medical Inc.
- InControl Medical LLC
- UroMems Inc.
- Rigicon Inc.
- Valencia Technologies Corporation
- Zephyr Surgical Implants SA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.37 Billion |
| Forecasted Market Value ( USD | $ 1.91 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
